| Form type | Sec Links | Description | Filing date | Reporting date |
|---|
Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-K | Report | Data | 10-K | Feb 5, 2025 | Dec 31, 2024 |
| 8-K | Report | Data | 8-K | Feb 4, 2025 | Feb 4, 2025 |
| 8-K | Report | Data | FORM 8-K | Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Report | Data | 10-Q | Oct 31, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | 8-K | Oct 31, 2024 | Oct 31, 2024 |
| 8-K | Report | Data | FORM 8-K | Oct 7, 2024 | Oct 7, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 1, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 1, 2024 | Aug 1, 2024 |
| 8-K | Report | Data | FORM 8-K | Jul 8, 2024 | Jul 8, 2024 |
| 8-K | Report | Data | FORM 8-K | Jun 20, 2024 | Jun 14, 2024 |
| 10-Q | Report | Data | 10-Q | May 2, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 2, 2024 | May 2, 2024 |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 9, 2024 | |
| SC 13G/A | Report | Feb 9, 2024 | ||
| 10-K | Report | Data | 10-K | Feb 5, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Feb 2, 2024 | Feb 2, 2024 |
| 8-K | Report | Data | FORM 8-K | Jan 31, 2024 | Jan 26, 2024 |
| SC 13G/A | Report | Jan 25, 2024 | ||
| SC 13G/A | Report | FILING REGENERON PHARMACEUTICALS, INC. | Jan 25, 2024 | |
| SC 13G/A | Report | FILING REGENERON PHARMACEUTICALS, INC. | Jan 25, 2024 | |
| 8-K | Report | Data | FORM 8-K | Jan 8, 2024 | Jan 8, 2024 |
| 10-Q | Report | Data | 10-Q | Nov 2, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 2, 2023 | Nov 2, 2023 |
| 8-K | Report | Data | FORM 8-K | Oct 5, 2023 | Oct 5, 2023 |
| SC 13D/A | Report | SC 13D/A | Sep 27, 2023 | |
| 8-K/A | Report | Data | FORM 8-K/A | Sep 8, 2023 | Jun 9, 2023 |
| 8-K | Report | Data | FORM 8-K | Sep 8, 2023 | Sep 1, 2023 |
| SC 13D | Report | SC 13D | Aug 18, 2023 | |
| 10-Q | Report | Data | 10-Q | Aug 3, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 3, 2023 | Aug 3, 2023 |
| 8-K | Report | Data | FORM 8-K | Jun 14, 2023 | Jun 9, 2023 |
| 10-Q | Report | Data | 10-Q | May 4, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 4, 2023 | May 4, 2023 |
| 8-K | Report | Data | FORM 8-K | Apr 17, 2023 | Apr 14, 2023 |
| 8-K | Report | Data | FORM 8-K | Apr 10, 2023 | Apr 10, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 29, 2023 | Mar 27, 2023 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 13, 2023 | |
| SC 13G/A | Report | Feb 9, 2023 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 9, 2023 | |
| 10-K | Report | Data | 10-K | Feb 6, 2023 | Dec 31, 2022 |
| SC 13G/A | Report | Feb 3, 2023 | ||
| 8-K | Report | Data | 8-K | Feb 3, 2023 | Feb 3, 2023 |
| SC 13G | Report | FILING REGENERON PHARMACEUTICALS, INC. | Jan 11, 2023 | |
| 8-K | Report | Data | FORM 8-K | Jan 9, 2023 | Jan 9, 2023 |
| 8-K | Report | Data | FORM 8-K | Dec 20, 2022 | Dec 19, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 3, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 3, 2022 | Nov 3, 2022 |
| SC 13G/A | Report | Oct 11, 2022 | ||
| 8-K | Report | Data | FORM 8-K | Oct 3, 2022 | Oct 3, 2022 |